Acta Med. 2014, 57: 56-61
https://doi.org/10.14712/18059694.2014.40
THE VEGF AND BMP-2 LEVELS IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND THE RELATIONSHIP TO TREATMENT WITH TUMOUR NECROSIS FACTOR ALPHA INHIBITORS
Crossref Cited-by Linking
- Galal Salwa, Hassan Rasha Mohamed, Labib Hossam Salaheldin Abdelmohsen: Association of vascular endothelial growth factor serum levels with ankylosing spondylitis in Egyptian patients. Egypt Rheumatol Rehabil 2023, 50. <https://doi.org/10.1186/s43166-023-00179-9>
- Le Thi Hong Van, Kwon Sang-Mo: Vascular Endothelial Growth Factor Biology and Its Potential as a Therapeutic Target in Rheumatic Diseases. IJMS 2021, 22, 5387. <https://doi.org/10.3390/ijms22105387>
- Torres L., Klingberg E., Nurkkala M., Carlsten H., Forsblad-d’Elia H.: Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis. Osteoporos Int 2019, 30, 441. <https://doi.org/10.1007/s00198-018-4721-4>
- Dohan Ehrenfest David M., Pinto Nelson R., Pereda Andrea, Jiménez Paula, Corso Marco Del, Kang Byung-Soo, Nally Mauricio, Lanata Nicole, Wang Hom-Lay, Quirynen Marc: The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane. Platelets 2018, 29, 171. <https://doi.org/10.1080/09537104.2017.1293812>